Health
Tocilizumab cuts mortality risk in severely ill COVID-19 patients finds new trial conducted in India – Medical Xpress
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial…
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across Indiaone of the world’s most ethnically diverse countries. Researchers from the University of Bristol and Medanta Institute of Education and Research in India who led the study, published in The Lancet Respiratory Medicine, say it adds to existing evidence supporting the drug’s use in critically ill patients.
…
-
Noosa News22 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News22 hours agoHunt for suspects after family’s pregnant horse found shot dead on rural Queensland property
-
General23 hours agoLabor to squeeze public service, sparking warnings of job losses
-
Noosa News22 hours agoInsurers scramble after severe storms and hail slam southeast Queensland